Glaucoma is a chronic eye disorder characterized by elevated intraocular pressure, which can lead to optic nerve damage and irreversible vision loss if untreated. Acetazolamide, a carbonic anhydrase inhibitor, effectively reduces aqueous humor production, but conventional ocular formulations are limited by poor bioavailability, rapid precorneal clearance, and the need for frequent dosing. To address these challenges, an acetazolamide-loaded in-situ cubogel was developed to provide sustained, targeted, and patient-friendly ocular delivery.Cubosomes were prepared using the top-down technique and optimized through a Box-Behnken Design. The optimized cubosome formulation contained 6.2% w/v Glyceryl monooleate, 0.35% w/v Pluronic F127 and 6.8 minutes sonication time, resulting in particle size of 256.7 nm, PDI of 0.473, zetapotential of 7.53 mV and entrapment efficiency of 80.35 %. Cryo-TEM confirmed the presence of well-ordered cubic nanostructures, and the dispersion was homogeneous, smooth, milky white and physically stable under storage conditions.In conclusion, the study successfully developed a stable, effective and patient-friendly acetazolamide in-situ cubogel.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Dr. Farhad F Mehta, working as Assistant Professor (C) at School of Pharmaceutical Sciences, Rajiv Gandhi Proudyogiki Vishvavidyalaya, Bhopal, Madhya Pradesh, India. He has published more than 56 research, review papers and authored Eleven Books in various reputed peer reviewed journals/publications and has been granted more than 76 IPR'S.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Home-set, Mannheim, Deutschland
Softcover/Taschenbuch. Zustand: Neu. Neuware, Lieferung aus Deutschland. Sprache: Englisch Gewicht in Gramm: 161. Artikel-Nr. IB-1615700
Anzahl: 2 verfügbar